搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
8 小时
on MSN
Preserving muscle with GLP-1 weight loss drugs: Big deal or nothing to worry about?
On the surface, the formula for weight loss seems simple: eat less and move more. But giving that advice to someone with ...
6 天
on MSN
2024 was the year of weight loss for Floridians. Wondering why?
For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.
4 天
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...
3 天
Katherine Ryan hits back at weight loss jab claims as her own daughter accuses her of ...
IT’S become one of the most popular ways in the showbiz world to stay slim. But Katherine Ryan has hit back at claims she’s ...
FiercePharma
2 天
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
10 天
Which State Medicaid Programs Cover GLP-1s for Weight Loss & How Much Are They Spending?
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
12 天
Biocon, Zentiva secure EU approval for generic diabetes and weight loss drugs
Biocon and Zentiva gain EU approval for generic Liraglutide, marking milestone in expanding complex generic medication ...
12 天
Biocon, Zentiva get EU approval for generic diabetes, weight management drug
Biocon and Zentiva receive EU approval for Liraglutide, a complex formulation for diabetes and weight management.
Seeking Alpha on MSN
1 天
Novo Nordisk seeks to block compounded Victoza
Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈